SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001628280-23-029155
Filing Date
2023-08-14
Accepted
2023-08-11 20:39:43
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 forms-3shelfaugust2023.htm S-3 703073
2 EX-FILING FEES ex107calculationoffilingfe.htm EX-FILING FEES 53175
3 EX-5.1 ex51legalopinions-3august2.htm EX-5.1 48330
4 EX-23.1 ex-231pwcconsentsx3shelf20.htm EX-23.1 2062
5 image.jpg GRAPHIC 2029
6 image_0a.jpg GRAPHIC 4094
  Complete submission text file 0001628280-23-029155.txt   816393
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-273961 | Film No.: 231165841
SIC: 2836 Biological Products, (No Diagnostic Substances)